subsidiaries of ShoreView Industries' portfolio company

has been acquired by

Contact Us

On September 3, 2021, Avidity Science, a portfolio company of ShoreView Industries and a worldwide leader in life science research tools, sold its subsidiaries of Lab Products, LLC and Harford Systems, LLC to Gen Cap America, Inc. ("Gen Cap"), a private equity firm focused on lower middle market buyouts.

The Healthcare M&A practice of Duff & Phelps, A Kroll Business, served as exclusive financial advisor to Avidity Science in connection with the transaction.

About Avidity Science 
Avidity Science is a worldwide leader in water purification and delivery, control and monitoring and service solutions for the life science and biomedical research communities. Since 1969, our mission has been to enable science to improve the quality of life. With operations in the United States, Europe, and Asia, we are a trusted partner to the global research community through unrivaled technology and support. Sidley Austin LLP served as legal counsel to Avidity Science.
 
About Lab Products/Harford Systems
Established in 1969, Lab Products & Harford Systems are a world leader in the design and manufacture of research model housing solutions. Our patented technologies address research issues of protecting research models and scientific personnel, efficient use of available area and operational efficiency.
 
About Gen Cap America 
Gen Cap America, Inc. is a Nashville-based private equity firm that provides equity for management buyouts, division spinoffs, and recapitalizations of profitable, well-established lower middle market businesses. Bass, Berry & Sims PLC served as legal counsel to Gen Cap America.

2021-09-16T00:00:00.0000000 /-/media/assets/images/transactions/2021/lab-products-harford-systems.png /-/media/assets/images/transactions/2021/avidity-science.png /-/media/assets/images/transactions/2021/gencap-america.png /about-us/transactions/m-and-a/sell-side-advisor-avidity-science case study {D59CA77E-C551-45A3-BE89-F567210C5A60} {4DACD310-421A-42AC-BEF4-8AA7E70484CD} {DC6234F2-03B5-4F3D-9CDE-146A80B170AD} {D3AE3EC6-3254-4441-B111-1AF8D558906C} {6B6F3B01-98A6-4BC2-B2CD-CBD127447FB5} {5CE144D0-ADDC-43A3-95E4-3428CA819BF8} {13E28841-C245-441D-8C3B-49E72DA5381C} {A7EB9162-FD06-4A2C-9E52-7BE04F16488F} {DF0A8D82-EB98-4261-8951-BF842E034FA8} {B871D4F9-5FCB-40B9-8710-871A30B710AB}

Other Areas We Can Help

Corporate Finance

Comprehensive support throughout mergers and acquisitions and other corporate transactions.

Corporate Finance

M&A Advisory

Middle-market M&A advisory differentiated by industry expertise and superior deal execution.

M&A Advisory

Healthcare M&A

Healthcare expertise for middle-market M&A transactions.

Healthcare M&A
Transaction Advisory Services

Transaction Advisory Services

Seamless analytical advisory through the deal continuum, from transaction origination to closing.

Transaction Advisory Services
Private Capital Markets

Private Capital Markets

Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.

Private Capital Markets

Financial Sponsors Group

Dedicated coverage and access to M&A deal-flow for financial sponsors.

Financial Sponsors Group

Related Case Studies

Insights

M&A Advisory

Healthcare Services Sector Update – Autumn 2021

M&A Advisory
Valuation

LNG Market Outlook Brief and Key Take-aways in a Fast-changing Environment

Valuation
M&A Advisory

European Chemicals Update – Q3 2021

M&A Advisory

News